Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
Global Human Hepatitis B Immunoglobulin (HBIG) Market Growth 2025-2031
... to grow at a CAGR of %from 2025 to 2031. United States market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Global Dog Vaccines Market Size Study, by Vaccine Type (Modified/Attenuated Live, Inactivated, Other Vaccines), by Disease Type (Canine Distemper, Canine Infectious Respiratory Disease Complex (CIRDC), Canine Parvovirosis/Parvovirus Disease, Canine Leptospirosis, Canine Lyme Disease, Infectious Canine Hepatitis, Canine Rabies), by Route of Administration (Injectables, Oral, Intranasal), by Duration of Immunity (1 Year, 3 Year, Others), by Component (Combined Vaccines, Mono Vaccines), and Regional Forecasts 2022-2032
... Hepatitis, Canine Rabies), by Route of Administration (Injectables, Oral, Intranasal), by Duration of Immunity (1 Year, 3 Year, Others), by Component (Combined Vaccines, Mono Vaccines), and Regional Forecasts 2022-2032 Global Dog Vaccines Market is valued ... Read More
-
Hepatitis B Virus Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type
... and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030. For geography segment, regional supply, demand, major players, price is ... Read More
-
Global Hepatitis B and C Diagnostics Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Hepatitis B and C Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Hepatitis C Therapeutics: Competitive Landscape
... cases of Hepatitis C (HCV) infection in 2024, which is expected to increase slightly to 25.84 million diagnosed prevalent cases by 2029. The HCV treatment landscape has experienced successive waves of revolutionary change and is ... Read More
-
Global Hepatitis B Therapeutics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Hepatitis B Therapeutics is forecast to a readjusted size of US$ 3020.8 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential ... Read More
-
Global Hepatitis B Testing Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Hepatitis B Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
PEGylated Proteins Market Size, Share, By Type (Consumables, and Services), By Protein (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, and Other), By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic and Research Institutes), and By Region - Trends, Analysis and Forecast till 2034
... End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic and Research Institutes), and By Region - Trends, Analysis and Forecast till 2034 PEGylated Proteins Market is experiencing significant growth, driven by increasing demand for ... Read More
-
Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form (Liquid, Lyophilized) Type (Live Attenuated, mRNA, Inactivated), Route of Administration (Intramuscular, Subcutaneous, Oral), Approach, Indication, Packaging – Global Forecast to 2031
... Size, Share, Forecast, & Trends Analysis by Form (Liquid, Lyophilized) Type (Live Attenuated, mRNA, Inactivated), Route of Administration (Intramuscular, Subcutaneous, Oral), Approach, Indication, Packaging – Global Forecast to 2031 According to a new market research ... Read More
-
Global Hepatitis B and C Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Hepatitis B diagnostic tests include HBV serologic tests, molecular ... Read More
-
Global Hepatitis B Immune Globulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Hepatitis B immune globulin (HBIG) is a type of blood product ... Read More
-
2024-2029 Hepatitis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
... market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. As ... Read More
-
Global Hepatitis B Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The Global Info Research report includes an overview of the development of the ... Read More
-
2024-2029 Europe Hepatitis Diagnostic Market for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT: France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, ... Read More
-
Global Hepatitis B Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 3125.7 million by 2030 with a CAGR of 2.9% during review period. The global pharmaceutical market is 1475 billion USD in 2022, growing ... Read More
-
2024-2029 Germany Hepatitis Diagnostic Market for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... Technologies, Instrumentation and Opportunities The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume ... Read More
-
Hepatitis B Therapeutics: Competitive Landscape
... cases of HBV in 2024, which is expected to increase to 22.43 million diagnosed prevalent cases by 2029. The HBV treatment landscape has experienced successive waves of revolutionary change and is now dominated by antivirals ... Read More
-
Global Hepatitis B Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In ... Read More
-
North America Hepatitis B Infection Market
... the forecast period of 2024 to 2031. North America Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (U.S., Canada and Mexico)- ... Read More
-
Asia Pacific Hepatitis B Infection Market
... forecast period of 2024 to 2031. Asia-Pacific Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (China, India, Japan, South Korea, Singapore, ... Read More
-
Europe Hepatitis B Infection Market
... period of 2024 to 2031. Europe Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (Germany, U.K., France, Italy, Spain, Russia, Netherlands, ... Read More
-
Global Hepatitis B Infection Market
... period of 2024 to 2031. Global Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (U.S., Canada and Mexico, China, India, Japan, ... Read More
-
Middle East and Africa Hepatitis B Infection Market
... CAGR of 5.2% in the forecast period of 2024 to 2031. Middle East and Africa Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, ... Read More
Research Assistance
